OBSERVATIONAL STUDY OF ANEMIC PATIENTS WITH PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) CONVERTING FROM DARBEPOETIN ALFA (DARB) TO EPOETIN ALFA (EPO)

被引：0
|
作者：
Lunde, Martin [1 ]
Jackson, James [2 ]
Lunacsek, Orsolya [2 ]
Bailey, Robert A. [3 ]
Senbetta, Mekre
McKenzie, R. Scott [3 ]
机构：
[1] Twin Cities Clin Res, Minneapolis, MN USA
[2] Xcenda LLC, Palm Harbor, FL USA
[3] Centocor Ortho Biotech Serv LLC, Horsham, PA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2011年 / 57卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
176
引用
收藏
页码：A60 / A60
页数：1
相关论文
共 50 条
  • [41] Dosing intervals and hemoglobin control in patients with chronic kidney disease and anemia treated with epoetin alfa or darbepoetin alfa: A retrospective cohort study
    Nurko, Saul
    Spirko, Rita
    Law, Amy
    Dennis, Vincent W.
    CLINICAL THERAPEUTICS, 2007, 29 (09) : 2010 - 2021
  • [42] Pharmacokinetic and pharmacodynamic profiles of extended dosing of epoetin alfa in anemic patients who have chronic kidney disease and are not on dialysis
    McGowan, Tracy
    Vaccaro, Nicole M.
    Beaver, Jessica S.
    Massarella, Joseph
    Wolfson, Marsha
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (04): : 1006 - 1014
  • [43] EPOETIN ALFA UTILIZATION FROM 2000 THROUGH 2007 FOR CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS
    Lafeuille, Marie-Helene
    Bailey, Robert A.
    McKenzie, R. Scott
    Vekeman, Francis
    Picch, Catherine Tak
    Lefebvre, Patrick
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A50 - A50
  • [44] Preference for monthly darbepoetin alfa dosing in patients with chronic kidney disease not receiving dialysis dialysis
    Hoggard, Jeffrey
    Crouch, Thomas
    McMurray, Stephen
    Levine, Michael
    Prathikanti, Radha
    Scarlata, Debra
    Audhya, Paul
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (10) : 2023 - 2030
  • [45] Hematologic outcomes and costs in epoetin alfa (EPO) and darbepoetin alfa (DARB) treated cancer patients with anemia: results of the Dosing and Outcomes Study of Erythropoiesis Stimulating Therapies (DOSE Registry).
    Memisoglu, A
    Peake, C
    Vichare, R
    McKenzie, RS
    Howell, J
    Piech, CT
    PHARMACOTHERAPY, 2005, 25 (10): : 1469 - 1469
  • [46] Darbepoetin alfa once monthly corrects anaemia in patients with chronic kidney disease not on dialysis
    Roger, Simon D.
    Kolmakova, Elena
    Fung, Maple
    Malecki, Robert
    Vinhas, Jose
    Dellanna, Frank
    Thomas, Mark
    Manamley, Nick
    Ferenczi, Sandor
    NEPHROLOGY, 2014, 19 (05) : 266 - 274
  • [47] EXTEND: AN OBSERVATIONAL COHORT STUDY OF EXTENDED DOSING WITH ARANESP® (DARBEPOETIN ALFA) IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS - INTERIM ANALYSIS
    Suranyi, M. G.
    Tolman, C.
    NEPHROLOGY, 2009, 14 : A50 - A51
  • [48] Hemoglobin Variability With Extended Dosing of Epoetin Alfa in Patients With Chronic Kidney Disease and Not on Dialysis
    Bailey, Robert A.
    McGowan, Tracy
    Tang, K. Linda
    Langholff, Wayne K.
    Lantz, Keith C.
    Wolfson, Marsha
    DIALYSIS & TRANSPLANTATION, 2009, 38 (10) : 407 - +
  • [49] Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients
    Ravani, Pietro
    Maas, Renke
    Malberti, Fabio
    Pecchini, Paola
    Mieth, Maren
    Quinn, Robert
    Tripepi, Giovanni
    Mallamaci, Francesca
    Zoccali, Carmine
    PLOS ONE, 2013, 8 (09):
  • [50] Cost-effectiveness of epoetin alfa in patients on chronic kidney dialysis
    Hollenbeak, Christopher
    Davies, Andrew
    McClellan, William M.
    de Lissovoy, Gregory
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A45 - A45
12345